Consensus-based disease definitions for endocrine immune-related adverse events of immune checkpoint inhibitors.
Zhu L, Cheung YM, Chiang C, Gallagher EJ, Hamnvik OR, Mammen J, Quandt Z, Jones R, McDunn J, Al-Bahadili H, Angell T, Bancos I, Betof Warner A, Blackwell S, Calabrese C, Cho TA, Dougan M, Ferreira M, Funchain P, Herndon J, Johnson DB, Kennedy R, Kheterpal M, Khouri M, Lechner MG, Lim AM, Markova A, Meara A, Overton L, Perdigoto AL, Sachithanandan N, Sharon E, Spain L, Tsai K, Yarchoan M, Reynolds KL, Shariff A.
Zhu L, et al. Among authors: sachithanandan n.
J Immunother Cancer. 2025 Oct 15;13(10):e011865. doi: 10.1136/jitc-2025-011865.
J Immunother Cancer. 2025.
PMID: 41093625
Free PMC article.